Risk factors

Altimmune added substantial new risk disclosures regarding term loan debt covenants, trade tariffs, and AI-driven cybersecurity threats this year.

Amprius Technologies faces new geopolitical and trade risks, including potential US tariffs on Chinese imports and supply chain rules under the National Defense Authorization Act.

Merger-related execution, regulatory approval, integration, and shareholder-value risks are prominent this year.

Underwriting, claims, catastrophe exposure and reinsurance dominate ASIC’s risk section.

Clinical-stage biotech company with history of significant net losses developing novel psychedelic therapies for mental health disorders.

Auddia faces significant going concern doubts with cash funding operations only into Q2 2026. The company added substantial merger-related risks concerning the pending transaction with Thramann Holdings. Financing facilities including equity lines and an ATM program create ongoing dilution and share price pressures.

The filing drops separate commercial biometrics-demand and stock-litigation risks while retaining related market-acceptance and volatility language.

Bridger Aerospace refinanced its debt in October 2025, expanding facilities to $231.5M and adding variable interest rate exposure risks. The company subleases three hangars and one ramp at Bozeman Yellowstone International Airport with renewal risks.

Black Spade Acquisition III is a blank check company with no revenue or operating history. The company faces significant cross-border risks due to its focus on potential business combinations in China.

The company faces an acute cash shortage, requiring $20 million by 2027 to avoid bankruptcy while operating with only 6 employees. Technical challenges with Symphony cartridges and specimen stability threaten the planned 2027 FDA 510(k) submission.

BKV expanded its debt significantly to $610.0 million, driven by senior notes and credit facility borrowings.

Goodwill and other identifiable intangible assets increased significantly to $194.1 million as of December 31, 2025, compared to $95.7 million in the prior year.